SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-079339
Filing Date
2023-07-10
Accepted
2023-07-10 08:00:21
Documents
1
Period of Report
2023-07-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320922-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320922-1_4seq1.xml 4 3840
  Complete submission text file 0001104659-23-079339.txt   5171
Mailing Address 27 RIPPLEVALE GROVE LONDON X0 N1 1HS
Business Address
Mosseri Marlio Charles (Reporting) CIK: 0001806384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 231078254

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations